Anti-IFN-beta (Capture), clone 4F9

Anti-IFN-beta (Capture), clone 4F9
Artikelnummer Größe Datenblatt Manual SDB Lieferzeit Menge Preis
E-AN002700P.25 25 µg - -

7 - 16 Werktage*

158,00 €
E-AN002700P.100 100 µg - -

7 - 16 Werktage*

426,00 €
E-AN002700P.1 1 mg - -

7 - 16 Werktage*

1.715,00 €
 
Type I interferon cytokine that plays a key role in the innate immune response to infection,... mehr
Produktinformationen "Anti-IFN-beta (Capture), clone 4F9"
Type I interferon cytokine that plays a key role in the innate immune response to infection, developing tumors and other inflammatory stimuli.Signals via binding to high-affinity (IFNAR2) and low-affinity (IFNAR1) heterodimeric receptor, activating the canonical Jak-STAT signaling pathway resulting in transcriptional activation or repression of interferon-regulated genes that encode the effectors of the interferon response, such as antiviral proteins, regulators of cell proliferation and differentiation, and immunoregulatory proteins. Signals mostly via binding to a IFNAR1-IFNAR2 heterodimeric receptor, but can also function with IFNAR1 alone and independently of Jak-STAT pathways. Elicits a wide variety of responses, including antiviral and antibacterial activities, and can regulate the development of B-cells, myelopoiesis and lipopolysaccharide (LPS)-inducible production of tumor necrosis factor. Plays a role in neuronal homeostasis by regulating dopamine turnover and protecting dopaminergic neurons: acts by promoting neuronal autophagy and alpha-synuclein clearance, thereby preventing dopaminergic neuron loss. IFNB1 is more potent than interferon-alpha (IFN-alpha) in inducing the apoptotic and antiproliferative pathways required for control of tumor cell growth. Protein function: Type I interferon cytokine that plays a key role in the innate immune response to infection, developing tumors and other inflammatory stimuli (PubMed:10708458, PubMed:23872679). Signals via binding to high-affinity (IFNAR2) and low-affinity (IFNAR1) heterodimeric receptor, activating the canonical Jak-STAT signaling pathway resulting in transcriptional activation or repression of interferon-regulated genes that encode the effectors of the interferon response, such as antiviral proteins, regulators of cell proliferation and differentiation, and immunoregulatory proteins. Signals mostly via binding to a IFNAR1-IFNAR2 heterodimeric receptor, but can also function with IFNAR1 alone and independently of Jak-STAT pathways (PubMed:23872679). Elicits a wide variety of responses, including antiviral and antibacterial activities, and can regulate the development of B-cells, myelopoiesis and lipopolysaccharide (LPS)- inducible production of tumor necrosis factor (PubMed:10708458, PubMed:14597717). Plays a role in neuronal homeostasis by regulating dopamine turnover and protecting dopaminergic neurons: acts by promoting neuronal autophagy and alpha-synuclein clearance, thereby preventing dopaminergic neuron loss (PubMed:26451483). IFNB1 is more potent than interferon-alpha (IFN-alpha) in inducing the apoptotic and antiproliferative pathways required for control of tumor cell growth (PubMed:14597717). [The UniProt Consortium]
Schlagworte: Ifb, IFN-beta, Interferon beta, IFN-beta Monoclonal Antibody(Capture)
Hersteller: Elabscience
Hersteller-Nr: E-AN002700P

Eigenschaften

Anwendung: ELISA Capture
Antikörper-Typ: Monoclonal
Klon: 4F9
Konjugat: No
Wirt: Rat
Spezies-Reaktivität: mouse
Immunogen: Recombinant Mouse IFN-beta protein expressed by Mammalian

Handhabung & Sicherheit

Lagerung: +4°C
Versand: +4°C (International: +4°C)
Achtung
Nur für Forschungszwecke und Laboruntersuchungen: Nicht für die Anwendung im oder am Menschen!
Hier kriegen Sie ein Zertifikat
oder , um Analysenzertifikate anzufordern.
Bewertungen lesen, schreiben und diskutieren... mehr
Kundenbewertungen für "Anti-IFN-beta (Capture), clone 4F9"
Bewertung schreiben
oder , um eine Produktbewertung abzugeben.
Zuletzt angesehen